Office of the Securities and Exchange Commission SorThor. 41/2543 Re: Approval for the Execution of Derivatives Transaction Outside the Stock Exchange of Thailand 08/09/2000 26/09/2000 6. Report/Form
Office of the Securities and Exchange Commission SorThor. 41/2543 Re: Approval for the Execution of Derivatives Transaction Outside the Stock Exchange of Thailand 08/09/2000 26/09/2000 6. Report/Form
of applying for approval for accepting clients’ trading orders of capital market products outside the office and for performing other duties from home in line with the New Normal standard. The SEC
. Operating performance summary for the period ended September 30, 2017 Unit: million baht July-September January-September 2017 2016 Variance 2017 2016 Variance Amount % Amount % Net profit (loss) for the
increase in Revenues from hospital operations. Administrative expenses (including Depreciation and amortization) were Baht 128.42 million in 2018 or 28.57% more than Baht 99.88 million in 2017. The variance
amortization) were Thai Baht 195.04 million in 2019 or 51.88% more than Thai Baht 128.42 million in 2018. The variance was mostly due to an increase in employee expenses and sales promotion expenses. EBITDA
-year from Baht 27.64 million in 1Q18. The variance was mostly due to an increase in number of patients, depreciation and employee management expenses. EBITDA increased by 112.55% year- over-year to Baht
variance was mostly due to an increase in employee expenses. Profit to equity holders of the company in 1Q20 decreased by 74.83% year‐over‐year to THB 11.25 million from THB 44.70 million in
and its subsidiaries performance are the comparative performance of the year of 2017 and the year of 2016; Table: Operating Results (Unit: Million Baht) Items Quarter Variance Quarter Variance For years
and its subsidiaries performance are the comparative performance of the year of 2017 and the year of 2016; Table: Operating Results (Unit: Million Baht) Items Quarter Variance Quarter Variance For years